Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivo
- PMID: 17383899
- PMCID: PMC2735870
- DOI: 10.1016/j.neuroimage.2007.02.019
Detection and measurement of neurofibromatosis-1 mouse optic glioma in vivo
Abstract
One of the major limitations to preclinical mouse therapeutic evaluation is the inherent difficulty in imaging small tumors in vivo. We present a rapid and reliable method to detect optic glioma (OPG) in a mouse neurofibromatosis-1 model (Nf1(flox/mut)GFAP-Cre mice) in vivo using Manganese-Enhanced Magnetic Resonance Imaging (MEMRI). In a blinded study, 23 mice were chosen randomly from a cohort of Nf1(flox/mut)GFAP-Cre mice and two sets of age-matched controls. In all cases, OPG presence or absence was correctly identified. In addition, the OPG size and shape were accurately measured in vivo, facilitating the use of this model for preclinical drug studies.
Figures



References
-
- Aoki I, Wu YJL, Silva AC, Lynch RM, Koretsky AP. In vivo detection of neuroarchitecture in the rodent brain using manganese-enhanced MRI. NeuroImage. 2004;22:1046–1059. - PubMed
-
- Bajenaru ML, Garbow JR, Perry A, Hernandez MR, Gutmann DH. Natural History of Neurofibromatosis1-Associated Optic Nerve Glioma in Mice. Ann. Neurol. 2005;57(1):119–127. - PubMed
-
- Bajenaru ML, Hernandez MR, Perry A, Y Z, Parada LF, Garbow JR, Gutmann DH. Optic Nerve Glioma in Mice Requires Astrocyte Nf1 Gene Inactivation and Nf1 Brain Heterozygosity. Cancer Res. 2003;63:8573–8577. - PubMed
-
- Listernick R, Charrow J, Greenwald M, Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J. Pediatr. 1994;125:63–66. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous